PHARMACYTE BIOTECH, INC. (PMCB)

Every figure this model derived for PMCB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-04-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 18,857,909 CashAndCashEquivalentsAtCarryingValue 2026-04-30
current assets 37,420,554 AssetsCurrent 2026-04-30
current liabilities 826,424 LiabilitiesCurrent 2026-04-30
equity 33,294,926 StockholdersEquity 2026-04-30
ocf -5,152,914 NetCashProvidedByUsedInOperatingActivities 2026-04-30
revenue 0 Revenues 2026-04-30
sbc 892,500 ShareBasedCompensation 2026-04-30

The ratios

The figures themselves rather than their scores — what somebody looking up PMCB on one particular measure came for.

RatioValue
current ratio45.28
current ratio reported45.28
dilution pct14.32
roic-37.5

What to be careful about

What this model itself distrusts about PMCB's figures. Written by the derivation as it ran, not added afterwards.